These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31403246)

  • 61. Synthetic paclitaxel-octreotide conjugate reversing the resistance of A2780/Taxol to paclitaxel in xenografted tumor in nude mice.
    Chen X; Zhang XY; Shen Y; Fan LL; Ren ML; Wu YP
    Oncotarget; 2016 Dec; 7(50):83451-83461. PubMed ID: 27825139
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monitorable Mitochondria-Targeting DNAtrain for Image-Guided Synergistic Cancer Therapy.
    Jiang T; Zhou L; Liu H; Zhang P; Liu G; Gong P; Li C; Tan W; Chen J; Cai L
    Anal Chem; 2019 Jun; 91(11):6996-7000. PubMed ID: 31088071
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cyanine-based NIR fluorescent probe for monitoring H
    Xiong J; Xia L; Huang Q; Huang J; Gu Y; Wang P
    Talanta; 2018 Jul; 184():109-114. PubMed ID: 29674020
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
    Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
    Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preparation of a Multiple-Targeting NIR-Based Fluorogenic Probe and Its Application for Selective Cancer Cell Imaging.
    Li H; Lee CH; Shin I
    Org Lett; 2019 Jun; 21(12):4628-4631. PubMed ID: 31184188
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thienylpiperidine Donor NIR Xanthene-Based Dye for Photoacoustic Imaging.
    Rathnamalala CSL; Pino NW; Herring BS; Hooper M; Gwaltney SR; Chan J; Scott CN
    Org Lett; 2021 Oct; 23(19):7640-7644. PubMed ID: 34550707
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cyanine-Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells.
    Jiang Z; Pflug K; Usama SM; Kuai D; Yan X; Sitcheran R; Burgess K
    J Med Chem; 2019 Oct; 62(20):9236-9245. PubMed ID: 31469566
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent.
    Wu J; Zhou Y; Li S; Qu D; Zhu WH; Tian H
    Biomaterials; 2017 Mar; 120():1-10. PubMed ID: 28011190
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A turn-on NIR fluorescence and colourimetric cyanine probe for monitoring the thiol content in serum and the glutathione reductase assisted glutathione redox process.
    Maity D; Govindaraju T
    Org Biomol Chem; 2013 Apr; 11(13):2098-104. PubMed ID: 23306953
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    Vats K; Satpati D; Sharma R; Kumar C; Sarma HD; Dash A
    J Labelled Comp Radiopharm; 2017 Jul; 60(9):431-438. PubMed ID: 28545160
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Precisely Traceable Drug Delivery of Azoreductase-Responsive Prodrug for Colon Targeting via Multimodal Imaging.
    Zhao XB; Ha W; Gao K; Shi YP
    Anal Chem; 2020 Jul; 92(13):9039-9047. PubMed ID: 32501673
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Redox-responsive xanthene-coumarin-chlorambucil-based FRET-guided theranostics for "activatable" combination therapy with real-time monitoring.
    Gangopadhyay M; Mengji R; Paul A; Venkatesh Y; Vangala V; Jana A; Singh NDP
    Chem Commun (Camb); 2017 Aug; 53(65):9109-9112. PubMed ID: 28759056
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Altering Fundamental Trends in the Emission of Xanthene Dyes.
    Wang LG; Munhenzva I; Sibrian-Vazquez M; Escobedo JO; Kitts CH; Fronczek FR; Strongin RM
    J Org Chem; 2019 Mar; 84(5):2585-2595. PubMed ID: 30719911
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A colorimetric and turn-on NIR fluorescent probe based on xanthene system for sensitive detection of thiophenol and its application in bioimaging.
    Guo SH; Leng TH; Wang K; Wang CY; Shen YJ; Zhu WH
    Talanta; 2018 Aug; 185():359-364. PubMed ID: 29759212
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bifunctional peptide hybrids targeting the matrix of mitochondria.
    Klimpel A; Neundorf I
    J Control Release; 2018 Dec; 291():147-156. PubMed ID: 30367921
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Discovery of peptide drug carrier candidates for targeted multi-drug delivery into prostate cancer cells.
    Bashari O; Redko B; Cohen A; Luboshits G; Gellerman G; Firer MA
    Cancer Lett; 2017 Nov; 408():164-173. PubMed ID: 28888997
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
    Jiao Y; Sun Y; Tang X; Ren Q; Yang W
    Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer.
    Wang M; Liu W; Zhang Y; Dang M; Zhang Y; Tao J; Chen K; Peng X; Teng Z
    J Colloid Interface Sci; 2019 Mar; 538():630-637. PubMed ID: 30554096
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cyanine dye mediated mitochondrial targeting enhances the anti-cancer activity of small-molecule cargoes.
    Nödling AR; Mills EM; Li X; Cardella D; Sayers EJ; Wu SH; Jones AT; Luk LYP; Tsai YH
    Chem Commun (Camb); 2020 Apr; 56(34):4672-4675. PubMed ID: 32211623
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Real-time imaging tracking of a dual-fluorescent drug delivery system based on doxorubicin-loaded globin- polyethylenimine nanoparticles for visible tumor therapy.
    Zhang Y; Wei C; Lv F; Liu T
    Colloids Surf B Biointerfaces; 2018 Oct; 170():163-171. PubMed ID: 29906701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.